Dr. Víctor Moreno and Dr. Ditsuhi Iskandaryan participated in the ESMO AI and Digital Oncology Congress 2025, held in Berlin from November 12-14.
They took the opportunity to present the latest results of the TANGERINE project, which aims to develop an artificial intelligence tool capable of predicting the response and toxicity to immunotherapy in patients with different types of cancer, as well as ExCaPT, a predictive model based on a transformative encoder designed to identify individuals at higher risk of developing cancer.
The ESMO AI conference aims to foster collaboration between healthcare professionals and digital health. It is an essential platform for oncology professionals to gain knowledge about advances in artificial intelligence and digital health, keeping them at the forefront of digital transformation in cancer care.
